MONOCLONAL
Clinical trials for MONOCLONAL explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL trials appear
Sign up with your email to follow new studies for MONOCLONAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis early-phase trial is testing a new drug called budoprutug (TNT119) in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Participants receive two IV doses and are monitored for safety, how the drug mov…
Matched conditions: MONOCLONAL
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Scientists study mast cells to unlock mastocytosis mysteries
Knowledge-focused Recruiting nowThis study collects bone marrow and blood samples from up to 600 people with mastocytosis, a condition where too many mast cells cause symptoms like itching and bone pain. Researchers will study what makes these cells grow and survive. The goal is to learn more about the disease,…
Matched conditions: MONOCLONAL
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC